Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
about
Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.Accuracy of empiric gentamicin dosing guidelines in neonatesExtended-interval gentamicin dosing in achieving therapeutic concentrations in malaysian neonatesGentamicin in neonates at risk for sepsis - peak serum concentrations are not necessaryClinical Pharmacology Studies in Critically Ill Children.Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example.Gentamicin trough levels using a simplified extended-interval dosing regimen in preterm and term newborns.Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.High-dose gentamicin in newborn infants: is it safe?
P2860
Q28393038-CD06D715-A537-4503-BF36-833154D22675Q34589031-47359564-B2A9-4D44-B52C-810F068B2114Q35566356-BA657A29-513E-4DDA-BC26-3D0F58B0B048Q36051172-3403A5E6-ABD3-4A9A-B371-0180257A1E41Q36120465-D8C02B93-6190-4899-B9FD-24BA55761363Q37933379-B2A6625C-FA5B-4951-90D7-EABF4494B291Q38215682-AFE1DB8D-07B2-4D9E-8CB3-C283E520EB18Q41494950-4ADAAA9D-DD92-44FC-976E-9D4333B55D01Q41667164-17ADED12-A662-433D-8E3D-BCFF9042E52EQ44891914-F71B9CED-B332-4D12-BEA1-AEE7930B6DE0Q50356292-78B08062-21CA-4C21-97FA-538EEEF255B8
P2860
Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@en
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@nl
type
label
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@en
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@nl
prefLabel
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@en
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacokinetic outcomes of a ...... ol in critically ill neonates.
@en
P2093
Amy R Commers
David S Hoff
Lisa M Tollefson
Meixia Liu
Polina G Lipnik
Roger A Wilcox
P2860
P304
P356
10.1592/PHCO.29.11.1297
P407
P577
2009-11-01T00:00:00Z